Company Filing History:
Years Active: 1999-2007
Title: David B Young: Innovator in Mitogen-Activated Protein Kinase Research
Introduction
David B Young is a prominent inventor based in San Diego, CA (US). He has made significant contributions to the field of biochemistry, particularly in the area of mitogen-activated protein kinases. With a total of 4 patents to his name, Young's work has the potential to impact the treatment of various diseases.
Latest Patents
One of his latest patents focuses on "Mitogen-activated protein kinase p38-2 and methods of use therefor." This patent provides compositions and methods for treating diseases associated with mitogen-activated protein kinase cascades. Specifically, it details the use of the mitogen-activated protein kinase p38-2 and its polypeptide variants, which stimulate phosphorylation and activation of substrates such as ATF2. These polypeptides can be utilized to identify antibodies and other agents that either inhibit or activate signal transduction via the p38-2 kinase cascade. The implications of this research are significant for developing treatments for diseases linked to these signaling pathways.
Career Highlights
David B Young is currently associated with Signal Pharmaceuticals, Inc., where he continues to advance his research. His work has garnered attention in the scientific community, contributing to the understanding of complex biochemical processes.
Collaborations
Throughout his career, Young has collaborated with notable colleagues, including Bernd M Stein and Maria X H Yang. These partnerships have enriched his research and expanded the scope of his innovations.
Conclusion
David B Young is a key figure in the field of mitogen-activated protein kinase research, with a focus on developing therapeutic methods for disease treatment. His contributions through patents and collaborations highlight his commitment to advancing scientific knowledge and improving healthcare outcomes.